The Venture Leaders Biotech 2021 kick off their international roadshow at the Swiss Biotech Day
The 10 Venture Leaders Biotech could not have found a more fitting event to kick off the international roadshow that will take them to Boston in the fall: The entrepreneurs presented their innovations at the Swiss Biotech Day in Basel. As one of the leading biotechnology conferences in Europe, the event provided the 10 new Swiss National Startup Team members with the opportunity to network and get to know each other. Venture Leaders Biotech 2021 is co-organized by Venturelab and Swissnex and supported by EPF Lausanne, ETH Zurich, VISCHER, and the Canton of Zurich.
“The Venture Leaders Biotech startups 2021 demonstrate Switzerland’s position as a global biotech hub that provides high-quality innovation that will transform our future,” said Jordi Montserrat, managing partner at Venturelab. “With the upcoming roadshow to Boston, we want to facilitate connections and investment opportunities for the Venture Leaders Biotech 2021 so that their innovative power can reach its full potential.”
The kick-off event marked the first time the 10 Venture Leaders Medtech met and presented their startups in person. During the one-day workshop at the Swiss Biotech Day in Basel, the 10 Venture Leaders Biotech focused on getting to know each other and preparing for the roadshow to Boston in the fall.
Christian Wyss and Nadia Tarolli Schmidt, two attorneys at law at Venture Leaders partner VISCHER, gave the entrepreneurs critical advice to winning over and onboarding international investors. “We are excited and humbled to join forces with this outstanding group of biotech entrepreneurs. We are convinced their trip to Boston will open ample opportunities for investments, partnering deals, and talent retention. As the leading Swiss law firm for biotech, we are looking forward to covering their backs in all legal matters,” explained Christian Wyss.
For the Venture Leaders Biotech, the roadshow and the surrounding events advance professional and personal growth: “The Venture Leaders program will support Nemosia’s mission in many facets: Provide industry experts’ feedback and advisory on our business model and product launch strategy, offer visibility and fundraising and investors networking opportunities, help us develop international partnership and distribution channels, and enable learning and exchange with fellow entrepreneurs,” summarized Awa Diagne, the co-founder and CEO of Nemosia. Rajesh Jayachandran, the CSO of NextImmune, added, “I look forward to getting acquainted with passionate and like-minded people in various phases and streams of entrepreneurial activity and introspect those strategies needed to realize one’s dream in this volatile and demanding field.”
Follow the entrepreneurs and the Venture Leaders Biotech roadshow on social media using the hashtag #VLeadersBiotech or on www.venture-leaders.ch/biotech.
Venture Leaders Biotech 2021 is co-organized by Venturelab and Swissnex and supported by EPF Lausanne, ETH Zurich, VISCHER, and the Canton of Zurich.
Learn more about the Venture Leaders Biotech 2021:
cellvie AG: From cells to medicine
cellvie is bringing about a new treatment modality, leveraging the therapeutic potential of mitochondria. Specifically, it was shown that mitochondria, the powerhouses of the cell, can be augmented an... Read more
deepCDR Biologics AG: Antibody discovery enabled by deep learning.
We harness the power of machine learning to move beyond experimental screening found in traditional therapeutic antibody discovery and engineering processes. To achieve this, we combine three state-of... Read more
HexagonFab AG: Low-cost drug discovery tools
Designing, developing and commercializing nanomaterial-based biosensors for life science analysis that require high-sensitive, rapid and real-time results (e.g. protein interaction analysis). Read more
InCephalo AG: Next generation drug delivery for almost any drug modality
InCephalo is a preclinical stage biotech company founded in May 2021. InCephalo's six (6) founders with various backgrounds came together with the vision of making a difference in the lives of those b... Read more
Nemosia AG: The missing link in the fight against neurodegeneration!
At Nemosia, we aim to raise public awareness of neurological disorders and promote a culture where it is seen as normal and safe to do regular brain check-ups even if there are no visible symptoms. W... Read more
NXI Therapeutics AG: Novel Therapy for Autoimmunity and Organ Transplantation.
NXI Therapeutics intends to commence operations with screening and preclinical development of compounds that interfere with coronin 1-dependent T cell activation in autoimmune diseases and organ tran... Read more
Related articles
Biotech startup cellvie gets USD 5.5 million to develop treatments for mitochondria dysfunction
read more
Venture Leaders Biotech 2022: 10 innovative startups will advance their global growth in Boston
read more
Applications are open for the Venture Leaders Biotech roadshow 2022
read more
The Venture Leaders Biotech dive into the Boston ecosystem
read more
Meet Abologix president Ignacio Faus and find out how he develops smart antibodies for cancer patients
read more
Meet Acthera co-CEO and CSO Pierre-Alain Monnard and discover how he advances innovation in targeted drug release
read more
Meet Nemosia co-founder Awa Diagne and discover how they provide the missing piece in the fight against neurodegeneration
read more
Meet NextImmune co-founder Rajesh Jayachandran and find out how he advances the development of novel immunosuppressants
read more
Meet Avrion Therapeutics CEO Maximilien Murone and discover how he develops precision gene therapies for neurological disorders
read more
Meet HexagonFab co-founder Christoph von Bieberstein and discover how he simplifies the analysis of proteins and small molecules
read more
Meet Gnubiotics Science CEO and CSO Yemi Adesokan and discover how he unlocks the power of the microbiome
read more
Meet Alithea Genomics’ co-founder Riccardo Dainese and find out how he simplifies high-throughput RNA sequencing
read more